Using gene editing to boost the production of SOD3 in the choroid plexus reduced oxidative damage to brain tissue and cerebral spinal fluid in mice exposed to methotrexate.
Researchers have uncovered the molecular mechanisms behind cognitive deficits and brain fog associated with chemotherapy, and identified a current FDA-approved drug for multiple sclerosis that can help reduce chemotherapy-induced cognitive impairments.
A new study reports a strong association between high levels of physical activity and the ability to maintain cognitive function in breast cancer patients who received chemotherapy.
Researchers have identified the 3D structure of a brain receptor that causes vomiting and nausea as a result of chemotherapy treatments for cancer. The same receptor also plays a critical role in pain perception, migraines and chronic itching.
A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
Chemotherapy is often blamed for memory loss and cognitive problems in cancer survivors. However, new research published in Neuroscience challenges this belief. Researchers report cognitive impairments, often referred to as Chemo Fog, may actually start as the tumor grows and develops.
Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.